On 13 June 2016, the Company granted 25,000 options to one of its directors, Mr Tristan Price, to subscribe for ordinary shares of 10p each in the Company ("Ordinary Shares"). The exercise price for these options granted under the Unapproved Executive Share-Option Plan 2012 is 410.5p per Ordinary Share, being the closing mid-market price on the dealing day prior to the date of the grant. These options are exercisable at any time between 13 June 2019 and 13 June 2026.
14 June 2016
Enquiries:
M.P. Evans Group PLC Telephone: 01892 516333
Peter Hadsley-Chaplin, Chairman
Tristan Price, Managing Director
Peel Hunt LLP Telephone: 0207418 8900
Dan Webster
Adrian Trimmings
George Sellar
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.